Provident Financial Services PFS Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies
Other financials
Where this comes from
Reported directly by Provident Financial Services in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.
The official record: Provident Financial Services’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Provident Financial Services's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Provident Financial Services's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
- Provident Financial Services (PFS) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $20.14 in Q4 2025.
- How has Provident Financial Services's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
- Provident Financial Services's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 1.3% year-over-year, from $19.89 to $20.14.
- What is the long-term trend for Provident Financial Services's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
- Over 5 years (2020 to 2025), Provident Financial Services's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a 2.3% compound annual growth rate (CAGR), from $17.96 to $20.14.